Medtronic adds to Intersect ENT's $30M Series D round

February 25, 2013 by Brad Perriello

Medtronic once again joins a $30 million funding round for Intersect Medical and its Propel sinus implants.

Intersect ENT
Medtronic

Medtronic (NYSE:MDT) is once again backing sinus implant developer Intersect ENT, this time in a $30 million Series D round led by new investor Norwest Venture Partners.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp